Orlando, FL (PRWEB) August 29, 2012
The Yaz Resource Center, a patient advocacy group, is alerting women who suffered side effects after taking the birth control drugs Yaz or Yasmin that the maker of these drugs has pledged additional funds to resolve injury claims. However, the time left to file a claim may be limited.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal rights.
On October 25, 2011, the British Medical Journal published a study from researchers at The University of Copenhagen which related the hormone in Yaz to blood clots. The FDA followed on October 27, 2011, releasing its own study titled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.
On May 31, 2012, the Institute for Safe Medicine Practices published its QuarterWatch report which ranked Yaz and Yasmin as the second-worst drugs in 2011 for the number of complications reported to the FDA.
Due to the number of patients that have filed a Yaz lawsuit, a federal Multi-District Litigation court was established in Illinois to handle the claims. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100). The court estimates that more than 10,000 patients have filed a claim.
On July 31st, Bloomberg News reported that Bayer’s second quarter stockholder newsletter stated the company faces nearly 13,000 Yaz lawsuits, but had begun settling the cases, with as many as 1900 settled so far. Bayer has reserved as much as $610 million to resolve the cases at an average of around $212,000 so far.
This could be positive news for those injured who have yet to file a claim. However, on July 11th, The Madison Record reported that Stephen Saltzburg, the special master appointed to oversee settlement negotiations for the federal court, estimated the cases could be concluded within a year.
Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible and find out eligibility for a Yaz lawsuit.
The Yaz Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.